Thibault Mesplede (Thibault Mesplèdes, Thibault Mesplède)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 23

Top Venues

Expert opinion on investigational drugs

Science advances

Journal of virology

AIDS research and human retroviruses

McGill University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

McGill University Aug 01 2017

Canada

Assistant Professor :: Microbiology and Immunology

Publications

Elliott R Rodríguez-López, Pablo López, Yadira Rodríguez, Raphael Sánchez, Van-Sergei Acevedo, Jarline Encarnación, Grissell Tirado, Carmen Ortiz-Sánchez, Thibault Mesplede, Vanessa Rivera-Amill
HIV-1 Integrase T218I/S Polymorphisms Do Not Reduce HIV-1 Integrase Inhibitors' Phenotypic Susceptibility. AIDS research and human retroviruses (2024)
Elliott R Rodríguez-López, Pablo López, Yadira Rodríguez, Raphael Sánchez, Van-Sergei Acevedo, Jarline Encarnación, Grissell Tirado, Carmen Ortiz-Sánchez, Thibault Mesplede, Vanessa Rivera-Amill
HIV-1 Integrase T218I/S Polymorphisms Do Not Reduce HIV-1 Integrase Inhibitors' Phenotypic Susceptibility. AIDS research and human retroviruses (2024)
Meng A Xiao, Jenna Cleyle, Sunbin Yoo, Mekayla Forrest, Zoë Krullaars, Hanh Thi Pham, Thibault Mesplede
The G118R plus R263K Combination of Integrase Mutations Associated with Dolutegravir-Based Treatment Failure Reduces HIV-1 Replicative Capacity and Integration. Antimicrobial agents and chemotherapy (2023)
Cynthia Lungu, Ronald J Overmars, Esmée Grundeken, Patrick H M Boers, Marchina E van der Ende, Thibault Mesplede, Rob A Gruters
Genotypic and Phenotypic Characterization of Replication-Competent HIV-2 Isolated from Controllers and Progressors. Viruses 15 (11) (2023)
Ronald J Overmars, Zoë Krullaars, Thibault Mesplede
Investigational drugs for HIV: trends, opportunities and key players. Expert opinion on investigational drugs (2023)
Ronald J Overmars, Zoë Krullaars, Thibault Mesplede
Investigational drugs for HIV: trends, opportunities and key players. Expert opinion on investigational drugs 32 (2) (2023)
Henrieke A B Prins, Raquel Crespo, Cynthia Lungu, Shringar Rao, Letao Li, Ronald J Overmars, Grigorios Papageorgiou, Yvonne M Mueller, Mateusz Stoszko, Tanvir Hossain, Tsung Wai Kan, Bart J A Rijnders, Hannelore I Bax, Eric C M van Gorp, Jan L Nouwen, Theodora E M S de Vries-Sluijs, Carolina A M Schurink, Mariana de Mendonça Melo, Els van Nood, Angela Colbers, David Marinus Burger, Robert-Jan Palstra, Jeroen J A van Kampen, David van de Vijver, Thibault Mesplede, Peter D Katsikis, Rob A Gruters, Birgit C P Koch, Annelies Verbon, Tokameh Mahmoudi, Casper Rokx
The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy. Science advances 9 (11) (2023)
Henrieke A B Prins, Raquel Crespo, Cynthia Lungu, Shringar Rao, Letao Li, Ronald J Overmars, Grigorios Papageorgiou, Yvonne M Mueller, Mateusz Stoszko, Tanvir Hossain, Tsung Wai Kan, Bart J A Rijnders, Hannelore I Bax, Eric C M van Gorp, Jan L Nouwen, Theodora E M S de Vries-Sluijs, Carolina A M Schurink, Mariana de Mendonça Melo, Els van Nood, Angela Colbers, David Marinus Burger, Robert-Jan Palstra, Jeroen J A van Kampen, David van de Vijver, Thibault Mesplede, Peter D Katsikis, Rob A Gruters, Birgit C P Koch, Annelies Verbon, Tokameh Mahmoudi, Casper Rokx
The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy. Science advances 9 (11) (2023)
Henrieke A B Prins, Raquel Crespo, Cynthia Lungu, Shringar Rao, Letao Li, Ronald J Overmars, Grigorios Papageorgiou, Yvonne M Mueller, Mateusz Stoszko, Tanvir Hossain, Tsung Wai Kan, Bart J A Rijnders, Hannelore I Bax, Eric C M van Gorp, Jan L Nouwen, Theodora E M S de Vries-Sluijs, Carolina A M Schurink, Mariana de Mendonça Melo, Els van Nood, Angela Colbers, David Marinus Burger, Robert-Jan Palstra, Jeroen J A van Kampen, David van de Vijver, Thibault Mesplede, Peter D Katsikis, Rob A Gruters, Birgit C P Koch, Annelies Verbon, Tokameh Mahmoudi, Casper Rokx
The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy. Science advances 9 (11) (2023)
Ronald J Overmars, Zoë Krullaars, Thibault Mesplede
Investigational drugs for HIV: trends, opportunities and key players. Expert opinion on investigational drugs 32 (2) (2023)
Henrieke A B Prins, Raquel Crespo, Cynthia Lungu, Shringar Rao, Letao Li, Ronald J Overmars, Grigorios Papageorgiou, Yvonne M Mueller, Mateusz Stoszko, Tanvir Hossain, Tsung Wai Kan, Bart J A Rijnders, Hannelore I Bax, Eric C M van Gorp, Jan L Nouwen, Theodora E M S de Vries-Sluijs, Carolina A M Schurink, Mariana de Mendonça Melo, Els van Nood, Angela Colbers, David Marinus Burger, Robert-Jan Palstra, Jeroen J A van Kampen, David van de Vijver, Thibault Mesplede, Peter D Katsikis, Rob A Gruters, Birgit C P Koch, Annelies Verbon, Tokameh Mahmoudi, Casper Rokx
The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy. Science advances 9 (11) (2023)
Ronald J Overmars, Zoë Krullaars, Thibault Mesplede
Investigational drugs for HIV: trends, opportunities and key players. Expert opinion on investigational drugs 32 (2) (2023)
Henintsoa Rabezanahary, Julien Clain, Gina Racine, Guadalupe Andreani, Ghita Benmadid-Laktout, Chloé Borde, Fabrizio Mammano, Thibault Mesplede, Petronela Ancuta, Ouafa Zghidi-Abouzid, Jérome Estaquier
Early Antiretroviral Therapy Prevents Viral Infection of Monocytes and Inflammation in Simian Immunodeficiency Virus-Infected Rhesus Macaques. Journal of virology 94 (22) (2020)
Koen K A Van Rompay, Said Hassounah, Brandon F Keele, Jeffrey D Lifson, Amir Ardeshir, Jennifer Watanabe, Hanh Thi Pham, Elena Chertova, Raymond Sowder, Jan Balzarini, Thibault Mesplede, Mark A Wainberg
Dolutegravir Monotherapy of Simian Immunodeficiency Virus-Infected Macaques Selects for Several Patterns of Resistance Mutations with Variable Virological Outcomes. Journal of virology 93 (2) (2019)
Hanh Thi Pham, Thibault Mesplede
Bictegravir in a fixed-dose tablet with emtricitabine and tenofovir alafenamide for the treatment of HIV infection: pharmacology and clinical implications. Expert opinion on pharmacotherapy 20 (4) (2019)
Yingshan Han, Hanh T Pham, Hongtao Xu, Yudong Quan, Thibault Mesplede
Antimalarial drugs and their metabolites are potent Zika virus inhibitors. Journal of medical virology 91 (7) (2019)
Steven Sanche, Thibault Mesplede, Nancy L Sheehan, Jun Li, Fahima Nekka
Exploring an alternative explanation for the second phase of viral decay: Infection of short-lived cells in a drug-limited compartment during HAART. PloS one 13 (7) (2018)
Yingshan Han, Thibault Mesplede
Investigational drugs for the treatment of Zika virus infection: a preclinical and clinical update. Expert opinion on investigational drugs 27 (12) (2018)
Thibault Mesplede, Jing Leng, Hanh Thi Pham, Jiaming Liang, Yudong Quan, Yingshan Han, Mark A Wainberg
Erratum for Mesplède et al., "The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration". mBio 9 (5) (2018)
Said A Hassounah, Thibault Mesplede
Where are we with injectables against HIV infection and what are the remaining challenges? Expert review of anti-infective therapy 16 (2) (2018)
Said A Hassounah, Ahmad Alikhani, Maureen Oliveira, Simrat Bharaj, Ruxandra-Ilinca Ibanescu, Nathan Osman, Hong-Tao Xu, Bluma G Brenner, Thibault Mesplede, Mark A Wainberg
Antiviral Activity of Bictegravir and Cabotegravir against Integrase Inhibitor-Resistant SIVmac239 and HIV-1. Antimicrobial agents and chemotherapy 61 (12) (2017)
Kaitlin Anstett, Bluma Brenner, Thibault Mesplede, Mark A Wainberg
HIV drug resistance against strand transfer integrase inhibitors. Retrovirology 14 (1) (2017)
Kaitlin Anstett, Bluma Brenner, Thibault Mesplede, Mark A Wainberg
HIV-1 Resistance to Dolutegravir Is Affected by Cellular Histone Acetyltransferase Activity. Journal of virology 91 (21) (2017)

Thibault Mesplede.css-eqlu8i{font-size:small;padding-left:4px;} (Thibault Mesplèdes, Thibault Mesplède)

Publication Activity (10 Years)

Top Topics

Top Venues

Thibault Mesplede (Thibault Mesplèdes, Thibault Mesplède)